课题基金 / 基金详情

Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer

Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
传染病和癌症疫苗和免疫疗法培训补助金
批准号:
10465086
负责人:
Matthias Johannes Schnell
金额:
$16.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-08-31

项目摘要

项目成果

Matthias Johannes Schnell的其他基金

相似基金

相关文献

中文摘要
翻译
总结 这是一个新的应用程序,提出了 3 名研究生和 2 名研究生的培训计划 针对微生物病原体和癌症的疫苗和免疫疗法的博士后研究员。 此申请的理由是利用 TJU 在该领域的长期经验 疫苗、治疗方法和癌症的研究,需要这样一个独特的培训机会 费城,以及在基础和基础方面发展“全面”培训经验的机会 病毒和肿瘤免疫的应用方面。 TPVIIDC的一个重要特点是 21位导师研究兴趣的多样性提供了一个机会 综合基础科学、疫苗开发和 疗法。而癌症免疫学或疫苗方面还有其他培训计划 针对传染病,历史上这些高度相关的疾病之间几乎没有交叉对话 研究领域。我们强烈认为我们的计划将有助于提供更好的培训 为癌症和传染病免疫学不同但相关的领域提供机会 疾病。虽然学生和研究员将大部分时间花在他们的寄宿家庭中 实验室的辅助机会将能够与广泛的参与人员进行互动 教师,通过共享研讨会、务虚会和课程提供来促进。
英文摘要
Summary This is a new application that proposes a training program for 3 graduate students and 2 postdoctoral fellows in vaccines and immunotherapies against microbial pathogens and cancer. The rationale for this application is to capitalize on the long-term experience of TJU in the area of vaccines, therapeutics and cancer, the need for a such a unique training opportunity in Philadelphia, and the opportunity to develop a “holistic” training experience in both basic and applied aspects of viral and tumor immunity. An important characteristic of the TPVIIDC is that the diversity of research interests of the 21 preceptors affords an opportunity to provide a comprehensive training experience that integrates basic science, vaccine development and therapeutics. Whereas there are other training programs in cancer immunology or vaccines against infectious diseases there is historically little cross-talk between these highly related research areas. We feel strongly that our program will help to provide better training by providing opportunities in different but related areas of immunology of cancer and infectious diseases. While the students and fellows will spend the majority of their time in their host laboratory, ancillary opportunities will enable interaction with a wide range of the participating faculty, facilitated by shared seminars, retreats and course offerings.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jneuroim.2021.577778
发表时间: 2022-01-15
期刊: Journal of neuroimmunology
影响因子: 3.3
作者: [Hwang D, Boehm A, Rostami A, Zhang GX, Ciric B]
通讯作者: Ciric B
DOI: 10.1073/pnas.2111804119
发表时间: 2022-04-05
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: []
通讯作者:
DOI: 10.1182/bloodadvances.2022008234
发表时间: 2022-12-13
期刊: BLOOD ADVANCES
影响因子: 7.5
作者: [Hwang, Daniel, Ishikawa, Larissa Lumi Watanabe, Seyedsadr, Maryam S., Mari, Elisabeth, Kasimoglu, Ezgi, Sahin, Ziver, Boehm, Alexandra, Jang, Soohwa, Rasouli, Javad, Vaccaro, Courtney, Gonzalez, Michael, Hakonarson, Hakon, Rostami, Abdolmohamad, Zhang, Guang-Xian, Ciric, Bogoljub]
通讯作者: Ciric, Bogoljub
Toward a protective Covid-19 vaccine utilizing an established vector platform
  • 批准号:
    10170820
  • 项目类别:
  • 资助金额:
    $42.9万
  • 财政年份:
    2020
  • 负责人:
    Matthias Johannes Schnell
  • 依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
  • 批准号:
    10078258
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    Matthias Johannes Schnell
  • 依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
  • 批准号:
    10311511
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    Matthias Johannes Schnell
  • 依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
  • 批准号:
    9905663
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2020
  • 负责人:
    Matthias Johannes Schnell
  • 依托单位:
海外基金